{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:47:17Z","timestamp":1793825237007,"version":"4.6.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Kidney transplantation is considered the most effective treatment for end-stage renal failure. Recent studies have shown that the significance of the immune microenvironment after kidney transplantation in determining prognosis of patients. Therefore, this study aimed to conduct a bibliometric analysis to provide an overview of the knowledge structure and research trends regarding the immune microenvironment and survival in kidney transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Our search included relevant publications from 2013 to 2023 retrieved from the Web of Science core repository and finally included 865 articles. To perform the bibliometric analysis, we utilized tools such as VOSviewer, CiteSpace, and the R package \u201cbibliometrix\u201d. The analysis focused on various aspects, including country, author, year, topic, reference, and keyword clustering.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Based on the inclusion criteria, a total of 865 articles were found, with a trend of steady increase. China and the United States were the countries with the most publications. Nanjing Medical University was the most productive institution. High-frequency keywords were clustered into 6 areas, including kidney transplantation, transforming growth factor \u03b2, macrophage, antibody-mediated rejection, necrosis factor alpha, and dysfunction. Antibody mediated rejection (2019-2023) was the main area of research in recent years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This groundbreaking bibliometric study comprehensively summarizes the research trends and advances related to the immune microenvironment and survival after kidney transplantation. It identifies recent frontiers of research and highlights promising directions for future studies, potentially offering fresh perspectives to scholars in the field.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1379742","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T04:54:44Z","timestamp":1711428884000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Relationship between the microenvironment and survival in kidney transplantation: a bibliometric analysis from 2013 to 2023"],"prefix":"10.3389","volume":"15","author":[{"given":"Chun-Lian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Li","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31283-7","article-title":"Strategies for long-term preservation of kidney graft function","volume":"389","author":"Wekerle","year":"2017","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603982","article-title":"Editorial: kidney transplantation and innate immunity","volume":"11","author":"Pontrelli","year":"2020","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.85gr.18001","article-title":"Kidney transplant: New opportunities and challenges","volume":"85","author":"Augustine","year":"2018","journal-title":"Cleveland Clinic J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"New Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-023-08012-1","article-title":"Survival benefit of solid-organ transplantation: 10-year update","volume":"68","author":"Ferreira","year":"2023","journal-title":"Digestive Dis Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/ajt.15913","article-title":"The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection","author":"Jordan","year":"2020","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002462","article-title":"Novel therapeutic approaches to allosensitization and antibody-mediated rejection","volume":"103","author":"Jordan","year":"2019","journal-title":"Transplantation"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/tri.2015.28.issue-5","article-title":"Evolution of allograft fibrosis and function in kidney transplant recipients: a retrospective analysis of stable patients under CNI and mTORi","volume":"28","author":"Becker","year":"2015","journal-title":"Transplant Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00074","article-title":"Extracellular vesicles as mediators of cellular crosstalk between immune system and kidney graft","volume":"11","author":"Quaglia","year":"2020","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab175","article-title":"A functional TGFB1 polymorphism in the donor associates with long-term graft survival after kidney transplantation","volume":"15","author":"Poppelaars","year":"2022","journal-title":"Clin Kidney J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003249","article-title":"Interleukin-6: an important mediator of allograft injury","volume":"104","author":"Jordan","year":"2020","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686530","article-title":"Highly purified alloantigen-specific tregs from healthy and chronic kidney disease patients can be long-term expanded, maintaining a suppressive phenotype and function in the presence of inflammatory cytokines","volume":"12","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1062456","article-title":"Highly purified and functionally stable in vitro expanded allospecific Tr1 cells expressing immunosuppressive graft-homing receptors as new candidates for cell therapy in solid organ transplantation","volume":"14","author":"Arteaga-Cruz","year":"2023","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11192-016-1885-6","article-title":"Scientific workflows for bibliometrics","volume":"107","author":"Guler","year":"2016","journal-title":"Scientometrics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000516185","article-title":"A bibliometric analysis of the one hundred most cited studies in psychosomatic research","volume":"90","author":"Shah","year":"2021","journal-title":"Psychother Psychosom"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14026","article-title":"Mapping the current trends and hotspots of vascular cognitive impairment from 2000-2021: A bibliometric analysis","volume":"29","author":"Han","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.997034","article-title":"A bibliometric analysis of RNA methylation in diabetes mellitus and its complications from 2002 to 2022","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.759347","article-title":"Study on pain catastrophizing from 2010 to 2020: A bibliometric analysis via citeSpace","volume":"12","author":"Luo","year":"2021","journal-title":"Front Psychol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2186684","DOI":"10.1080\/21645515.2023.2186684","article-title":"Visual analysis of global research on immunotherapy for gastric cancer: A literature mining from 2012 to 2022","volume":"19","author":"Chen","year":"2023","journal-title":"Hum Vaccines immunotherapeutics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.618737","article-title":"Combined immunotherapy with belatacept and BTLA overexpression attenuates acute rejection following kidney transplantation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0003842021","article-title":"Monocytes and macrophages in kidney transplantation and insights from single cell RNA-seq studies","volume":"2","author":"Malone","year":"2021","journal-title":"Kidney360"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27480","article-title":"Immunological biomarkers of tolerance in human kidney transplantation: An updated literature review","volume":"234","author":"Mirzakhani","year":"2019","journal-title":"J Cell Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003804","article-title":"Macrophages in transplantation: A matter of plasticity, polarization, and diversity","volume":"106","author":"Panzer","year":"2022","journal-title":"Transplantation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000737","article-title":"Cellular therapies in kidney transplantation","volume":"30","author":"Leclerc","year":"2021","journal-title":"Curr Opin Nephrol hypertension"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet (London England)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1089664","article-title":"Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation","volume":"14","author":"Schaier","year":"2023","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-015-1313-z","article-title":"Cell therapy for immunosuppression after kidney transplantation","volume":"400","author":"Morath","year":"2015","journal-title":"Langenbeck's Arch Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.3389\/ti.2023.11329","article-title":"Peripheral blood immune cell composition after autologous MSC infusion in kidney transplantation recipients","volume":"36","author":"Hendriks","year":"2023","journal-title":"Transplant Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.06.024","article-title":"Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection","volume":"102","author":"Lai","year":"2022","journal-title":"Kidney Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13882","article-title":"Splenic irradiation for the treatment of severe antibody-mediated rejection","volume":"16","author":"Orandi","year":"2016","journal-title":"Am J Transplant"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.suppl_1.114","article-title":"Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy","author":"Campistol","year":"2001","journal-title":"Nephrology dialysis Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41467-023-39050-y","article-title":"Intrinsic TGF-\u03b2 signaling attenuates proximal tubule mitochondrial injury and inflammation in chronic kidney disease","volume":"14","author":"Kayhan","year":"2023","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0712324","article-title":"Kidney transplantation: analysis of the expression and T cell-mediated activation of latent TGF-\u03b2","volume":"93","author":"Willet","year":"2013","journal-title":"J leukocyte Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-018-1900-7","article-title":"Relationship of transforming growth factor-\u03b2l and arginase-1 levels with long-term survival after kidney transplantation","volume":"38","author":"Du","year":"2018","journal-title":"Curr Med Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02978","article-title":"Effects of antirejection drugs on innate immune cells after kidney transplantation","volume":"10","author":"Zaza","year":"2019","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00354","article-title":"Cell therapy in organ transplantation: our experience on the clinical translation of regulatory T cells","volume":"9","author":"Safinia","year":"2018","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"107669","DOI":"10.1016\/j.intimp.2021.107669","article-title":"Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells","volume":"97","author":"Mansourabadi","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.565518","article-title":"The next frontier of regulatory T cells: promising immunotherapy for autoimmune diseases and organ transplantations","volume":"11","author":"Terry","year":"2020","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016111206","article-title":"Cell therapy in kidney transplantation: focus on regulatory T cells","volume":"28","author":"Zwang","year":"2017","journal-title":"J Am Soc Nephrol JASN"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.17116\/hirurgia201909180","article-title":"Control and prevention of kidney transplant rejection: the role and possibilities for the clinical use of regulatory T-cells in transplantation","author":"Mukhin","year":"2019","journal-title":"Khirurgiia"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1291649","article-title":"Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance","volume":"14","author":"Bei","year":"2023","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.08.037","article-title":"A Phase I\/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients","volume":"103","author":"Moreau","year":"2023","journal-title":"Kidney Int"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.06.015","article-title":"Tolerogenic dendritic cells: promising cell therapy for acute kidney injury","volume":"104","author":"Nakamura","year":"2023","journal-title":"Kidney Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16395","article-title":"Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients","volume":"21","author":"Harden","year":"2021","journal-title":"Am J Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1379742\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T04:54:46Z","timestamp":1711428886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1379742\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2024.1379742"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1379742","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"article-number":"1379742"}}